Sanis — supply status, manufacturers & alternatives

Sanis

—

In supply · Australia

In supply · 🇦🇺 Australia · short in🇨🇦 CA

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Sanis
Therapeutic category	Auto-created by Health Canada — Recalls and Safety Alerts scraper
Controlled substance	No
Marketing-authorisation holders	HAWCO PRODUCTS LTD., GERMIPHENE CORPORATION, BRISK CORPORATION, SANTEC PRODUCTS

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Recalls official enforcement reports

🇨🇦

Sanis

Drugs and health products · June 2025

Class IIdetails ↗

🇨🇦

Sanis Health Duloxetine 60 mg Capsule

Drugs and health products · May 2024

Class Idetails ↗

🇨🇦

Sanis Health Losartan / Losartan

Drugs and health products · Sept 2021

Class Idetails ↗

🇨🇦

Sanis Health Inc. Ranitidine Product

Drugs and health products · Sept 2019

Class Idetails ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders5 registrations · 4 MA holders

Product	Strength	Form	Market	MA holder	Status
Sanispray	—	spray	🇨🇦 CA	HAWCO PRODUCTS LTD.	Active
Sanisudz	—	solution	🇨🇦 CA	GERMIPHENE CORPORATION	Active
Sanisan Liq 4.8%	4.8%	liquid	🇨🇦 CA	BRISK CORPORATION	Active
Sanis Multipurpose Disinfectant Cleaner	—	liquid	🇨🇦 CA	SANTEC PRODUCTS	Active
Saniscrubz	—	wipe	🇨🇦 CA	GERMIPHENE CORPORATION	Dormant

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.